Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1951 1
1952 2
1968 1
1970 1
1973 1
1981 1
1985 1
1986 2
1987 2
1989 1
1990 2
1991 3
1992 3
1993 4
1994 2
1995 1
2000 1
2001 2
2003 1
2004 1
2005 1
2006 1
2007 3
2008 1
2009 6
2010 5
2011 6
2012 3
2013 5
2014 2
2015 1
2016 4
2017 5
2018 5
2019 4
2020 17
2021 18
2022 14
2023 12
2024 6

Text availability

Article attribute

Article type

Publication date

Search Results

136 results

Results by year

Filters applied: . Clear all
Page 1
Adjuvant immunotherapy with nivolumab versus observation in completely resected Merkel cell carcinoma (ADMEC-O): disease-free survival results from a randomised, open-label, phase 2 trial.
Becker JC, Ugurel S, Leiter U, Meier F, Gutzmer R, Haferkamp S, Zimmer L, Livingstone E, Eigentler TK, Hauschild A, Kiecker F, Hassel JC, Mohr P, Fluck M, Thomas I, Garzarolli M, Grimmelmann I, Drexler K, Spillner AN, Eckhardt S, Schadendorf D; DeCOG. Becker JC, et al. Among authors: drexler k. Lancet. 2023 Sep 2;402(10404):798-808. doi: 10.1016/S0140-6736(23)00769-9. Epub 2023 Jul 11. Lancet. 2023. PMID: 37451295 Clinical Trial.
Faziale Lipodystrophie nach Immuntherapie mit Nivolumab.
Drexler K, Zenderowski V, Berneburg M, Haferkamp S. Drexler K, et al. J Dtsch Dermatol Ges. 2021 Oct;19(10):1513-1515. doi: 10.1111/ddg.14588_g. J Dtsch Dermatol Ges. 2021. PMID: 34661354 German. No abstract available.
Machine-phase nanotechnology.
Drexler KE. Drexler KE. Sci Am. 2001 Sep;285(3):74-5. doi: 10.1038/scientificamerican0901-74. Sci Am. 2001. PMID: 11524972 No abstract available.
nan'o.tech.nol'o.gy n.
Theis T, Parr D, Binks P, Ying J, Drexler KE, Schepers E, Mullis K, Bai C, Boland JJ, Langer R, Dobson P, Rao CN, Ferrari M. Theis T, et al. Among authors: drexler ke. Nat Nanotechnol. 2006 Oct;1(1):8-10. doi: 10.1038/nnano.2006.77. Nat Nanotechnol. 2006. PMID: 18654128 No abstract available.
Potential Involvement of Extracellular Citrate in Brain Tumor Progression.
Jordan K, Stanton EH, Milenkovic VM, Federlin M, Drexler K, Buchalla W, Gaumann A, Adamski J, Proescholdt M, Haferkamp S, Geissler EK, Mycielska ME. Jordan K, et al. Among authors: drexler k. Curr Mol Med. 2022;22(6):506-513. doi: 10.2174/1566524021666210302143802. Curr Mol Med. 2022. PMID: 33653247 Review.
Extracellular Citrate Fuels Cancer Cell Metabolism and Growth.
Haferkamp S, Drexler K, Federlin M, Schlitt HJ, Berneburg M, Adamski J, Gaumann A, Geissler EK, Ganapathy V, Parkinson EK, Mycielska ME. Haferkamp S, et al. Among authors: drexler k. Front Cell Dev Biol. 2020 Dec 4;8:602476. doi: 10.3389/fcell.2020.602476. eCollection 2020. Front Cell Dev Biol. 2020. PMID: 33425906 Free PMC article. Review.
Facial lipodystrophy after immunotherapy with Nivolumab.
Drexler K, Zenderowski V, Berneburg M, Haferkamp S. Drexler K, et al. J Dtsch Dermatol Ges. 2021 Oct;19(10):1513-1515. doi: 10.1111/ddg.14588. Epub 2021 Sep 27. J Dtsch Dermatol Ges. 2021. PMID: 34569153 No abstract available.
136 results